Anticoagulation during and after acute coronary syndrome.

Abstract:

:Current antithrombotic therapy in patients with acute coronary syndrome (ACS) comprises antiplatelet and anticoagulant therapy. Dual antiplatelet therapy composed of aspirin plus a third generation P2Y12 inhibitor (prasugrel or ticagrelor) represents the gold standard, while aspirin plus second generation P2Y12 inhibitor (clopidogrel) may be used as an alternative in the presence of contraindications for third generation P2Y12 inhibitors and/or a high risk of bleeding. Unfractionated heparin (UFH) has been the unchallenged mainstay in anticoagulation for ACS for many decades and is still widely used in patients with ACS treated interventionally. Novel alternative parenteral anticoagulant strategies include the low molecular weight heparin enoxaparin and the synthetic pentasaccharide fondaparinux. Both of these agents share advantages over UFH particularly in medically treated patients with ACS not scheduled for PCI. The direct parenteral factor IIa (thrombin) inhibitor bivalirudin, when used as sole anticoagulant in patients with ACS undergoing PCI, is as effective as the regimen of UFH plus GPIIb/IIIa inhibitor in NSTEMI and superior to the latter regimen in patients with STEMI. The novel approach of a long-term low dose factor Xa inhibition with rivaroxaban in the post ACS phase even further reduced cardiovascular mortality in a clinical trial but has yet to be established in daily clinical practice in the setting of third generation P2Y12 inhibitors. This review discusses currently clinically established anticoagulants for the treatment of ACS alongside with novel approaches such as rivaroxaban.

journal_name

Hamostaseologie

journal_title

Hamostaseologie

authors

Ahrens I,Bode C,Zirlik A

doi

10.5482/HAMO-13-09-0048

subject

Has Abstract

pub_date

2014-01-01 00:00:00

pages

72-7

issue

1

eissn

0720-9355

issn

2567-5761

pii

13-09-0048

journal_volume

34

pub_type

杂志文章,评审
  • [Protein Z deficiency in unexplained affinity to thromboses, bleedings or abortions].

    abstract:UNLABELLED:A protein Z deficiency is presumably related with a threefold risk of venous and arterial thrombosis. Mucosal bleedings and post-operative haematomas can occur more frequently. This is seen in an increased in vivo bleeding time without other plasmatic coagulation disorders or thrombopathies. Pregnancy compli...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Kiesewetter H,Radtke H,Jainz A,Schmidt FP

    更新日期:2012-01-01 00:00:00

  • Thrombin generation and venous thromboembolism.

    abstract::Venous thromboembolism is a chronic and potential fatal disease. Determination of recurrence risk is time-consuming and costly, and sometimes not feasible: many patients carry more than one risk factor, the relevance of some factors with regard to risk of recurrence is unknown, and existence of thus far unknown risk f...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Eichinger S

    更新日期:2008-02-01 00:00:00

  • Coagulation Signalling and Metabolic Disorders: Lessons Learned from Animal Models.

    abstract::Nutrient excess in obesity drives metabolic reprogramming in multiple tissues involving extensive interorgan and intercellular crosstalk. Experimental and clinical studies show that prolonged nutrient excess often compromises metabolic adaptation propagating proobesogenic and proinflammatory responses. Chronic inflamm...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0039-1688800

    authors: Madhusudhan T,Ruf W

    更新日期:2019-06-01 00:00:00

  • [Haemophilia treatment centres in Germany].

    abstract:UNLABELLED:An adequate number of qualified haemophilia centres is an essential requirement for effective and cost-efficient haemophilia care. During a reassessment of the delivery of haemophilia care in Germany a broad range of criteria relating to structure and quality of the centres were defined and a questionnaire w...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Zimmermann R,Eifrig B,Lenk H,Pollmann H,Scharrer I,Huth-Kühne A

    更新日期:2012-01-01 00:00:00

  • Trauma-Induced Coagulopathy.

    abstract::Trauma-induced coagulopathy (TIC) is a heterogeneous entity that contributes to a significant morbidity and mortality following trauma. The activated protein C system, endotheliopathy and platelet dysfunction have been implicated in the pathogenesis of TIC, although there are still controversies on the exact pathogene...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0039-1677853

    authors: Petros S

    更新日期:2019-02-01 00:00:00

  • How Do I Reverse Oral and Parenteral Anticoagulants?

    abstract::An understanding of reversal strategies alone is important to safely and effectively care for patients in cases of bleeding or invasive procedures. The recent diversification in the number of licensed anticoagulants makes an understanding of drug-specific reversal strategies essential. Intravenous or oral vitamin K ca...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/a-1113-0557

    authors: Koscielny J,Rutkauskaite E,Sucker C,von Heymann C

    更新日期:2020-06-01 00:00:00

  • Diagnosis and treatment of superficial vein thrombosis.

    abstract::Superficial vein thrombosis (SVT) is a common disease, characterized by an inflammatory-thrombotic process in a superficial vein. Typical clinical findings are pain and a warm, tender, reddish cord along the vein. Until recently, no reliable epidemiological data were available. The incidence is estimated to be higher ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.5482/HAMO-13-04-0027

    authors: Bauersachs RM

    更新日期:2013-08-01 00:00:00

  • Management of acquired haemophilia A.

    abstract::Acquired haemophilia A (AHA) is caused by autoantibody inhibitors of coagulation factor VIII (FVIII : C). Recent onset of bleeds and isolated prolongation of the activated partial thromboplastin time (aPTT) are characteristic features of the disorder. Reduced FVIII : C activity and a detectable FVIII : C inhibitor in ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-11-0064

    authors: Tiede A,Scharf RE,Dobbelstein C,Werwitzke S

    更新日期:2015-01-01 00:00:00

  • [Future potential indications for an oral thrombin inhibitor].

    abstract::By the use of conventional anticoagulants, significant improvements were achieved in all fields of medicine. Although efficacious and widely used, their use is limited in several respects. In particular, the use of vitamin K antagonists is restricted in the clinical routine setting. The main reasons are the delayed on...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Haas S

    更新日期:2002-08-01 00:00:00

  • Potential of Multidimensional, Large-scale Biodatabases to Elucidate Coagulation and Platelet Pathways as an Approach towards Precision Medicine in Thrombotic Disease.

    abstract::Cardiovascular and especially thrombotic diseases remain a major cause of morbidity and mortality worldwide. In past years, significant improvements in understanding disease processes, risk assessment, and prediction of clinical outcome in the field of thrombosis and haemostasis have been made by using large-scale bio...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0038-1677520

    authors: Panova-Noeva M,Eggebrecht L,Prochaska JH,Wild PS

    更新日期:2019-06-01 00:00:00

  • Platelet monitoring for PCI: is it really necessary?

    abstract::Percutaneous coronary intervention (PCI) has significantly improved clinical outcomes in coronary artery disease patients. Since PCI is associated with platelet activation, antiplatelet therapy with aspirin, clopidogrel and GPIIb/IIIa inhibitors comprise the cornerstone strategy during and following PCI. The latter ag...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Tantry US,Gurbel PA

    更新日期:2009-11-01 00:00:00

  • Oxidative stress, NADPH oxidases, and arteries.

    abstract::Atherosclerosis and its major complications - myocardial infarction and stroke - remain major causes of death and disability in the United States and world-wide. Indeed, with dramatic increases in obesity and diabetes mellitus, the prevalence and public health impact of cardiovascular diseases (CVD) will likely remain...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-11-0076

    authors: Sun QA,Runge MS,Madamanchi NR

    更新日期:2016-05-10 00:00:00

  • VKCFD2 - from clinical phenotype to molecular mechanism.

    abstract::Vitamin K 2,3-epoxide reductase complex, subunit 1 (VKORC1) is an enzyme essential for the vitamin K cycle. VKORC1 catalyses the reduction of vitamin K 2,3-epoxide to the quinone form of vitamin K and further to vitamin K hydroquinone. The generated vitamin K hydroquinone serves as substrate for the enzyme γ-glutamyl-...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Czogalla KJ,Watzka M,Oldenburg J

    更新日期:2016-11-08 00:00:00

  • [A quarter century of psychosocial haemophilia-counseling].

    abstract:UNLABELLED:With the development of clotting-factors in the seventies the haemophilia patients were released from being handicapped and began to live a quite normal life. Thus, psychosocial counselling did not seem to be necessary. But the impact of HIV-infection to the world of haemophilia was so intense that professio...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Schneider MM,Schramm W

    更新日期:2010-11-01 00:00:00

  • Dabigatran for stroke prevention in atrial fibrillation.

    abstract::Dabigatran is a novel direct thrombin inhibitor that has recently been approved for primary and secondary stroke prevention and prevention of systemic embolism in patients with atrial fibrillation. In the pivotal RE-LY study, dabigatran 110 mg BID was demonstrated to be associated with a stroke rate similar to that ob...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.5482/ha-1196

    authors: Hohnloser SH,Diener HC

    更新日期:2012-01-01 00:00:00

  • Phospholipid inhibitors. State of the art.

    abstract::The antiphospholipid syndrome (APS) is defined by the association of arterial and/or venous thrombosis and/or pregnancy complications with the presence of at least one among the main antiphospholipid antibodies (aPL) (i. e., Lupus anticoagulants, LA, IgG and/or IgM anticardiolipin antibodies, aCL, IgG and/or IgM antiβ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/ha-1165

    authors: Galli M

    更新日期:2011-11-01 00:00:00

  • [Is the generally accepted therapeutic benefit of exercise training in patients with peripheral arterial occlusive disease evidence based? Analysis of the Cochrane review].

    abstract::When assessing the quality of clinical trials in intermittent claudication, on principle the same strict biometric and medical standards need to be applied for studies on the effect of walking exercise as for conservative drug treatment studies. However, as demonstrated by a recent review of the Cochrane Collaboration...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Amendt K

    更新日期:2006-08-01 00:00:00

  • Venous thrombosis and multiple prothrombotic gene defects. Case 5.

    abstract::We describe the case of a 30-year-old woman with homozygous prothrombin G20210A transition and heterozygous FV Leiden mutation and a history of postpartum venous thrombosis. Despite the high thrombotic risk to be assumed in the presence of this combined thrombophilia our patient suffered her first venous thrombotic ev...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Mengis C,Demarmels Biasiutti F

    更新日期:2003-08-01 00:00:00

  • Understanding and Preventing Placenta-Mediated Pregnancy Complications.

    abstract::Placenta-mediated pregnancy complications are clinically important conditions and include preeclampsia, placental abruption, intrauterine growth restriction, and late fetal loss. Pathophysiology is complex, and may be linked to prothrombotic disorders such as antiphospholipid syndrome, whose understanding is still evo...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1055/a-1184-8388

    authors: Skeith L,Blondon M,Ní Áinle F

    更新日期:2020-08-01 00:00:00

  • Apixaban for the Treatment of Chronic Disseminated Intravascular Coagulation: A Report of Two Cases.

    abstract::Characteristic features of disseminated intravascular coagulation (DIC) are the opposing risks of bleeding (due to consumptive coagulopathy and hyperfibrinolysis) and organ failure (due to widespread microvascular thromboses). The purpose of anticoagulation in DIC is to attenuate excessive thrombin generation and fibr...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.1055/s-0038-1675386

    authors: Janjetovic S,Holstein K,Dicke C,Bokemeyer C,Langer F

    更新日期:2019-08-01 00:00:00

  • [Factor XIII in man: a review].

    abstract::Activated by calcium and thrombin, factor XIII (FXIIIa) cross-links fibrin, thus increasing the stability of the fibrin clot. Furthermore, the hemostatic and reparative function of factor XIIIa is mediated by cross-linking other proteins like alpha(2)-plasmin-inhibitor, fibronectin, and collagen. The FXIII Val34Leu po...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Dufner GS,Marbet GA

    更新日期:2002-02-01 00:00:00

  • Extracellular nucleic acids as novel alarm signals in the vascular system. Mediators of defence and disease.

    abstract::Upon vascular injury or tissue damage, the exposed intracellular material such as nucleic acids, histones and other macromolecules may come into contact with vessel wall cells and circulating blood cells and may thus, have an enduring influence on wound healing and body defence processes. This short review summarizes ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-13-01-0001

    authors: Fischer S,Preissner KT

    更新日期:2013-01-01 00:00:00

  • Hermansky-Pudlak syndrome. Overview of clinical and molecular features and case report of a new HPS-1 variant.

    abstract::Hermansky-Pudlak syndrome (HPS) is a rare, autosomal recessive disorder affecting lysosome-related organelles (LRO), including dense platelet granules. HPS causes oculocutaneous hypopigmentation, bleeding diathesis and granulomatous colitis or pulmonary fibrosis. To date, there is no curative treatment and the clinica...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/HAMO-14-06-0024

    authors: Sánchez-Guiu I,Torregrosa JM,Velasco F,Antón AI,Lozano ML,Vicente V,Rivera J

    更新日期:2014-01-01 00:00:00

  • The Role of Low Molecular Weight Heparins for Venous Thromboembolism Prevention in Medical Patients-What Is New in 2019?

    abstract::Low molecular weight heparins and fondaparinux have been the cornerstones for prevention of venous thromboembolism (VTE) in acutely ill medical patients for almost two decades. Guidelines recommend the use of these parenteral anticoagulants for 6 to 14 days but advise against extended-duration thromboprophylaxis after...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0038-1677522

    authors: Haas S

    更新日期:2019-02-01 00:00:00

  • Clot waveform analysis in patients with haemophilia A.

    abstract:UNLABELLED:Clot waveform analysis extends the interpretation of aPTT measurement curves. The curve is mathematically processed to obtain information about fibrin formation kinetics including semiquantitative determination of thrombin, prothrombinase and tenase activity. PATIENTS, METHOD:In this study the feasibility o...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:10.5482/HAMO-14-02-0016

    authors: Siegemund T,Scholz U,Schobess R,Siegemund A

    更新日期:2014-01-01 00:00:00

  • [Inhibitor development after changing FVIII/IX products in patients with haemophilia].

    abstract:UNLABELLED:The retrospective observational study surveys the relationship between development of inhibitors in the treatment of haemophilia patients and risk factors such as changing FVIII products. A total of 119 patients were included in this study, 198 changes of FVIII products were evaluated. RESULTS:During the ob...

    journal_title:Hamostaseologie

    pub_type: 杂志文章

    doi:

    authors: Kocher S,Asmelash G,Makki V,Müller S,Krekeler S,Alesci S,Miesbach W

    更新日期:2012-01-01 00:00:00

  • [Congenital and acquired thrombocytopenias].

    abstract::An overview is given on congenital and acquired thrombocytopenias, their pathophysiology, symptoms, diagnosis and therapy with emphasizing heparin-induced thrombocytopenia (HIT) and the thrombotic thrombocytopenic purpura (TTP). ...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:

    authors: Scharf RE

    更新日期:2003-11-01 00:00:00

  • Cofactor-Independent Antiphospholipid Antibodies: Implications for Pathogenesis, Diagnosis, and Treatment of Antiphospholipid Syndrome.

    abstract::The antiphospholipid syndrome (APS) has occupied haemostaseologists, rheumatologists and obstetricians since its initial description 35 years ago. Its name has been coined because of the antibodies against phospholipids which were the common property of affected patients. In particular, the pathogenesis of APS has bee...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.1055/s-0038-1675355

    authors: Lackner KJ,Müller-Calleja N

    更新日期:2019-06-01 00:00:00

  • Vitamin K antagonists. Ready to be replaced?

    abstract::For the last decades, anticoagulation for stroke prevention in atrial fibrillation (AF) as well as for the prophylaxis and long-term treatment of venous thromboembolism has been entirely based on vitamin K antagonists (VKA). Although very effective under optimal conditions, long-term treatment with these drugs is flaw...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,评审

    doi:10.5482/ha-12050008

    authors: Steffel J,Luscher TF

    更新日期:2012-01-01 00:00:00

  • Follow-up of a 6-month Programmed Sports Therapy (PST) in patients with haemophilia.

    abstract::Studies describe benefits of exercise in Patients with haemophilia (PwH), but research on training sustainability is rare. Aim of this study was to observe the follow-up of a guided 6-month training intervention in PwH. This study included 28 PwH after a training intervention (RCT) over 6 months. N=17 continued traini...

    journal_title:Hamostaseologie

    pub_type: 杂志文章,随机对照试验

    doi:10.5482/HAMO-17-04-0016

    authors: Runkel B,Hilberg T

    更新日期:2017-01-01 00:00:00